[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Online Pharmacy – are patients better with a ‘face to face’?

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Regulation

Recent coverage in the Australian community pharmacy press has centred around the benefit and/or potential harm of prescribing and dispensing medicines without a face-to-face consultation.  The discussion raised asked the question whether an online questionnaire is...

Recent MHRA Alerts

by Jackie (née Heneghan) Peck | May 20, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

So much for all the wonders and claims of slimming tablets … After investigation, the MHRA has recently issued alerts about a number of products found to have prescription only drug ingredients in them.  All the alerts were raised by the Hong Kong Department of...

Export of medicines in short supply………

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

The PSNC is no longer maintaining a list as shortages have become part of every day life in pharmacy now. This posed a question by one of my clients: “Does this mean we can now export anything?” No I said you must not export drugs in short supply and I refereed him to...

RP & GDP Training for WDA(H)

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

RP – Responsible Person relating to MHRA GDP – Good Distribution Practice – the guidelines by which medicine wholesalers must adhere to WDA(H) – Wholesale Distribution Authorisation for Human Use – previously Wholesale Dealer’s...

Quality Agreements- Technical Agreements- Good ones are invaluable!

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Pharmacy Brands, Pharmacy Suppliers, Regulation

TAs – when do we need them in place and who with and what should be in them? PCL have been reviewing a few TAs over the last few weeks and we have put a few tips and hints together. If you only follow GDP or GMP; the principals are the same. If you are a...

The current state of Pfizer

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

Pfizer’s bid for AstraZeneca scrutinised – should it be only the shareholders who decide? AstraZeneca employs over six thousand people in the UK. Pfizer has made nine promises in a letter to David Cameron which are said to reflect Pfizer’s commitment to the UK....
« Older Entries
Next Entries »

Recent Posts

  • FDA Warning Letters
  • Emerging issues – Communique from the GPhC
  • New MHRA/NICE Collaboration

Upcoming Courses

  • RP Forum – GxP Certificates for Customers and Supplier Qualification on 9 September 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 10 September 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 16 September 2025
  • GDP Audit Online Training on 1 October 2025 10:00 am
  • Licence Holder Training on 14 October 2025 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 11 to 15 August 2025
19 August 2025
Class 4 Medicines Defect Notification: Levetiracetam Accord 100mg/ml oral solution, Accord Healthcare Limited, UK, EL(25)A/40
14 August 2025
Field Safety Notices: 4 to 8 August 2025
12 August 2025
Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd, EL(25)A/39
7 August 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow